Modern paradigms for prostate cancer detection and management

• Centre for Remote Health, Flinders University, Alice Springs, NT

---

• 1. Williams ISC, McVey A, Perera S, et al. Modern paradigms for prostate cancer detection and management. Med J Aust 2022; 217: 424‐433. https://www.mja.com.au/journal/2022/217/8/modern‐paradigms‐prostate‐cancer‐detection‐and‐management
• 2. Ilic D, Djulbegovic M, Jung JH, et al. Prostate cancer screening with prostate‐specific antigen (PSA) test: a systematic review and meta‐analysis. BMJ 2018; 362: k3519.
• 3. Royal Australian College of General Practitioners. Prostate cancer. In: Guidelines for preventive activities in general practice; 9th ed. Melbourne: RACGP, 2018. https://www.racgp.org.au/clinical‐resources/clinical‐guidelines/key‐racgp‐guidelines/view‐all‐racgp‐guidelines/guidelines‐for‐preventive‐activities‐in‐general‐pr/early‐detection‐of‐cancers/prostrate‐cancer (viewed Feb 2023).
• 4. National Health and Medical Research Council. PSA testing for prostate cancer in asymptomatic men — information for health practitioners. Canberra: NHMRC, 2014. https://www.nhmrc.gov.au/sites/default/files/documents/reports/clinical%20guidelines/men4d‐psa‐testing‐asymptomatic.pdf (viewed Feb 2023).
• 5. Jahn JL, Giovanni EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate‐specific antigen‐era. Int J Cancer 2015; 137: 2795‐2802.